October 20, 2026

Wave Life Sciences, Inc. (WVE): Investor Outlook on the Biotech’s 443% Potential Upside

Wave Life Sciences, Inc. (NASDAQ: WVE) is capturing headlines with its staggering potential upside of 443.17%, according to the average target price set by analysts. This..

MiMedx Group, Inc (MDXG) Stock Analysis: Exploring a 68.95% Potential Upside in Biotech

For investors with a keen eye on the biotechnology sector, MiMedx Group, Inc (NASDAQ: MDXG) emerges as a compelling story, particularly when considering its significant potential..

Phreesia, Inc. (PHR) Stock Analysis: Potential 23.52% Upside with Strong Buy Ratings

Phreesia, Inc. (PHR) is capturing investor attention with its robust potential upside and an impressive array of buy ratings from analysts. As of the latest trading..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Is a 26% Upside Within Reach?

Healthcare Services Group, Inc. (NASDAQ: HCSG) may not be the most talked-about name in the healthcare sector, but for investors keen on uncovering growth potential, this..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 134.62% Potential Upside in the Biotech Arena

Dyne Therapeutics, Inc. (NASDAQ: DYN), a dynamic player in the biotechnology sector, is capturing investor attention with an impressive potential upside of 134.62%. This clinical-stage company,..

Kestra Medical Technologies (KMTS) Stock Analysis: Navigating Growth with 59.9% Revenue Surge

Kestra Medical Technologies, Ltd. (KMTS), a prominent player in the healthcare sector, is making waves with its advanced wearable medical devices aimed at transforming outcomes for..

Structure Therapeutics Inc. (GPCR) Investor Outlook: A Promising Target with 380.61% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company, is catching the attention of investors with its impressive potential upside of 380.61%. Based in South..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Capitalizing on a 17.21% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX) operates at the intersection of healthcare and information services, providing consumers in the United States with the tools to compare and..

Integra LifeSciences Holdings C (IART): Investor Outlook Reveals 33.83% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors looking to diversify their healthcare portfolios...

agilon health, inc. (AGL) Stock Analysis: A Promising 30% Upside Amidst Healthcare’s Evolving Landscape

In the fast-evolving landscape of healthcare services, agilon health, inc. (NYSE: AGL) emerges as an intriguing player with a unique value proposition. Specializing in healthcare services..

NeoGenomics Inc. (NEO): Investor Outlook with a 33% Potential Upside

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, is capturing investor attention with its comprehensive cancer-focused..

PACS Group, Inc. (PACS)

⚠️ No article content returned.

..

Bausch Health Companies Inc. (BHC): Analyst Consensus and Investor Outlook Highlight a Promising 18.67% Upside

Bausch Health Companies Inc. (NYSE: BHC) has garnered considerable attention in the healthcare sector, specifically within the drug manufacturing space. With its diverse portfolio spanning gastroenterology,..

Artivion, Inc. (AORT) Stock Analysis: Exploring an 89% Potential Upside in the Healthcare Sector

Artivion, Inc. (NASDAQ: AORT) is making waves in the healthcare sector with its promising growth potential and innovative medical devices. With a market capitalization of $1.09..

QuidelOrtho Corporation (QDEL) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a 14.94% Potential Upside

QuidelOrtho Corporation (NASDAQ: QDEL), a stalwart in the healthcare sector specializing in medical devices, is a pivotal player in the diagnostic testing solutions market. Headquartered in..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Anticipating a 15.60% Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH), a prominent player in the healthcare sector, is capturing the attention of individual investors with its robust growth trajectory and..

Vera Therapeutics, Inc. (VERA): Exploring a 156% Potential Upside Amidst Strong Buy Ratings

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, has captured investor attention with its strong potential upside and promising pipeline focused on..

Evotec SE (EVO) Stock Analysis: Unveiling a Potential 198% Upside for Investors

Evotec SE (EVO), a notable player in the healthcare sector, is attracting attention with its significant potential upside of nearly 198%. This German-based drug discovery and..

The Pennant Group, Inc. (PNTG) Stock Analysis: A Strong Buy with 15% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is currently making waves in the healthcare sector, offering investors a compelling opportunity for growth and returns. With a market..

PROCEPT BioRobotics Corporation (PRCT): Investor Outlook Reveals 21.72% Potential Upside

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) has been making waves in the healthcare sector, specifically within the medical devices industry. Known for its cutting-edge robotic surgical systems,..

Search

Funds

October 20, 2026

Search

Funds

October 20, 2026

FTSE 100

Funds